… Antiretroviral therapy of HIV infection has changed a uniformly fatal into a potentially chronic
… use for HIV treatment. Patients who can access and adhere to combination therapy should …

… antiretroviral therapy (ART) in persons with HIV-1 infection reduces the risk of sexual
transmission of the virus. The multinational, randomized, controlled HIV … the transmission of HIV-1 …

… the concepts of antiretroviral therapy, barriers to successful antiretroviral treatment,
developments to limit treatment barriers, and new drug entities for the treatment of HIV. Key Words: …

… with ARV therapy and partly with HIV itself represent a new problem in medical practice.
When is the best time to start antiretroviral therapy? Which is the best ARV combination to start …

… A 48-week course of ART in patients with primary HIV infection delayed disease progression…
of highly active antiretroviral therapy (ART) in human immunodeficiency virus (HIV) disease …

… In all antiretroviral therapy groups, and also in the group of antiretroviral therapy-naive
patients, higher HIV viral load was associated with a decreased risk of elevated total cholesterol (…

… , we randomly assigned 4685 patients to receive immediate antiretroviral therapy (2326 …
Our results indicate that antiretroviral therapy should be recommended for patients in whom HIV …

… in about 70% of HIV-1 infected patients receiving antiretroviral therapy.5 , 56 Features of the
… in HIV patients such as insulin resistance and vascular inflammation, puts these patients at …

… living with HIV has … to patients, clinicians, and health-care planners. We examined changes
in 3 year survival and life expectancy of patients starting combination antiretroviral therapy (…

… of CD4 cell concentrations in patients whose plasma HIV-1 RNA is durably suppressed
by antiretroviral therapy, in patients with incomplete suppression of plasma HIV-1 RNA, and …